Looking forward, as a result of recent changes in our customer mix and market pricing, particularly for econazole nitrate
, we anticipate revenue from our econazole nitrate
cream products to decline in the second quarter of 2015.
0 million in cash through the sale of treasury stock to fund the purchase of the topical pharmaceutical product econazole nitrate cream 1%
0 million through the sale of treasury stock that we believe will enable us to accelerate revenue growth in 2013 with the purchase of econazole nitrate cream.
8 million related to price increases for IGI's econazole nitrate cream 1% product, which took effect in September 2014
8 million related to price protection for our customers after our price increase for econazole nitrate cream 1% took effect in September.
NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has entered into an agreement to purchase the topical pharmaceutical product Econazole Nitrate
Cream 1% from Prasco, LLC.
ECOZA(TM) FOAM, a novel alternative for the treatment of interdigital tinea pedis (athletes foot between the toes), combines the proven antifungal efficacy of econazole nitrate with the skin-restoring properties of Proderm Technology.
We are really excited about the launch of ECOZA(TM) FOAM, the first and only FDA approved prescription econazole nitrate foam in the U.
Food and Drug Administration (FDA) of its supplemental filing for the site transfer of econazole nitrate
cream 1%, to the company's manufacturing facility in Buena, NJ.
receives FDA first generic approval for Econazole Nitrate Cream 1% (Rx).
Econazole Nitrate Cream 1% (Rx) is the seventh product to join Fougera's 2002 roster for first FDA approvals.